SIREN : 339138638
DEDIENNE SANTE is a French company founded 39 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in MAUGUIO (34130), this company of category ETI shows in 2024 a revenue of 18.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18 519 595 € | 19 245 275 € | 16 861 122 € | 16 066 004 € | 14 094 205 € | 17 181 988 € | 18 181 045 € | 17 948 296 € |
| Net income | 3 097 942 € | -610 453 € | -1 705 151 € | -2 232 426 € | -7 408 018 € | -7 974 811 € | -2 060 088 € | -1 556 217 € |
| EBITDA | -70 252 € | 1 324 388 € | -357 397 € | -2 846 355 € | -3 365 797 € | -2 889 321 € | -708 110 € | 215 800 € |
| Net margin | 16.7% | -3.2% | -10.1% | -13.9% | -52.6% | -46.4% | -11.3% | -8.7% |
In 2024, DEDIENNE SANTE achieves revenue of 18.5 M€. Revenue is growing positively over 8 years (CAGR: +0.4%). Slight decline of -4% vs 2023. After deducting consumption (3.6 M€), gross margin stands at 14.9 M€, i.e. a rate of 80%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -70 k€, representing -0.4% of revenue. Warning negative scissor effect: despite revenue change (-4%), EBITDA varies by -105%, reducing margin by 7.3 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 3.1 M€, i.e. 16.7% of revenue. This profit can be retained or distributed to shareholders.
18 519 595 €
14 899 521 €
-70 252 €
-386 195 €
3 097 942 €
-0.4%
The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 22.8 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 0.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
20.104%
55.876%
0.417%
22.767
22.5%
In 2024, the debt ratio of DEDIENNE SANTE (20.10) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of DEDIENNE SANTE (55.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of DEDIENNE SANTE (22.77) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 274.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
274.27
-287.533
In 2024, the liquidity ratio of DEDIENNE SANTE (274.27) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of DEDIENNE SANTE (-287.5x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 29 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 78 days. Excellent situation: suppliers finance 49 days of the operating cycle (retail model). Inventory turnover is 181 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 210 days of revenue, i.e. 10.8 M€ to permanently finance. Notable WCR improvement over the period (-32%), freeing up cash.
10 781 553 €
29 j
78 j
181 j
210 j
Based on 57 transactions of similar company sales
(all years),
the value of DEDIENNE SANTE is estimated at
6 294 287 €
(range 2 048 303€ - 12 715 416€).
The price/revenue ratio is 0.23x
(conservative valuation).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare DEDIENNE SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire
The revenue of DEDIENNE SANTE in 2024 is 18.5 M€.
Yes, DEDIENNE SANTE generated a net profit of 3.1 M€ in 2024.
The headquarters of DEDIENNE SANTE is located in MAUGUIO (34130), in the department Herault.
The tax return of DEDIENNE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
DEDIENNE SANTE operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.